ArticleBMC gastroenterology2015

C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.

Ryota Iwasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.